Generex Biotechnology Corp (GNBT) - Financial and Strategic SWOT Analysis Review

December 2020 | 50 pages | ID: G90D4BFCB74EN
GlobalData

Abstracts

Generex Biotechnology Corp (GNBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using proprietary RapidMist device. Generex through its subsidiary, Antigen Express, has expanded its focus to include immunomedicines incorporating proprietary vaccine formulations for the treatment of infectious, malignant, allergic, and autoimmune diseases. Generex is headquartered in Miramar, Florida, the US.

Generex Biotechnology Corp Key Recent Developments

Oct 06,2020: Generex Subsidiary NuGenerex Immuno-Oncology announces world class Scientific Advisory Board appointments for its COVID-19 vaccine development program
Sep 25,2020: Generex Biotechnology subsidiary NuGenHealth contracts with Paradise Valley Family Medicine to provide Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) services
Aug 26,2020: Generex Biotechnology announces call-in details and updated agenda for shareholder conference call on Wednesday, August 26th, 2020 at 9:30 AM Eastern
Aug 17,2020: Generex Biotechnology announces agenda for shareholder conference call on wednesday August 26th, 2020 at 9:30 am
Jul 10,2020: Generex Biotechnology announces corporate update and investor conference call: NuGenerex Immuno-Oncology today friday July 10, 2020 at 4:15 PM

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Generex Biotechnology Corp - Key Facts
Generex Biotechnology Corp - Key Employees
Generex Biotechnology Corp - Key Employee Biographies
Generex Biotechnology Corp - Major Products and Services
Generex Biotechnology Corp - History
Generex Biotechnology Corp - Company Statement
Generex Biotechnology Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Generex Biotechnology Corp - Business Description
Generex Biotechnology Corp - Corporate Strategy
Generex Biotechnology Corp - SWOT Analysis
SWOT Analysis - Overview
Generex Biotechnology Corp - Strengths
Generex Biotechnology Corp - Weaknesses
Generex Biotechnology Corp - Opportunities
Generex Biotechnology Corp - Threats
Generex Biotechnology Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Generex Biotechnology Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 06, 2020: Generex Subsidiary NuGenerex Immuno-Oncology announces world class Scientific Advisory Board appointments for its COVID-19 vaccine development program
Sep 25, 2020: Generex Biotechnology subsidiary NuGenHealth contracts with Paradise Valley Family Medicine to provide Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) services
Aug 26, 2020: Generex Biotechnology announces call-in details and updated agenda for shareholder conference call on Wednesday, August 26th, 2020 at 9:30 AM Eastern
Aug 17, 2020: Generex Biotechnology announces agenda for shareholder conference call on wednesday August 26th, 2020 at 9:30 am
Jul 10, 2020: Generex Biotechnology announces corporate update and investor conference call: NuGenerex Immuno-Oncology today friday July 10, 2020 at 4:15 PM
Apr 17, 2020: Generex Biotechnology receives a letter of support from WCCT Global
Apr 14, 2020: Generex Biotechnology provides update on the development of an Ii-Key- SARS-CoV-2 peptide vaccine against the covid-19 pandemic
Apr 06, 2020: Generex Biotechnology CEO offers an open letter to shareholders and provides an update on corporate response to the COVID-19 pandemic
Mar 06, 2020: EpiVax partners with UGA researcher on Covid-19 vaccine
Mar 04, 2020: Generex signs contract with EpiVax to develop Ii-Key peptide vaccines to address the coronavirus pandemic

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Generex Biotechnology Corp, Key Facts
Generex Biotechnology Corp, Key Employees
Generex Biotechnology Corp, Key Employee Biographies
Generex Biotechnology Corp, Major Products and Services
Generex Biotechnology Corp, History
Generex Biotechnology Corp, Subsidiaries
Generex Biotechnology Corp, Key Competitors
Generex Biotechnology Corp, Ratios based on current share price
Generex Biotechnology Corp, Annual Ratios
Generex Biotechnology Corp, Annual Ratios (Cont...1)
Generex Biotechnology Corp, Interim Ratios
Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Generex Biotechnology Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Generex Biotechnology Corp, Performance Chart (2016 - 2020)
Generex Biotechnology Corp, Ratio Charts
Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020